The results also suggested that high expression of LPCAT1 was strongly linked to CD274, PDCD1, or CTLA-4 in HCC, indicating that targeting LPCAT1 might increase the efficacy of immunotherapy in LIHC. Here, PDCD1 is linked to hepatocellular carcinoma.